Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Wei Zhao

3PUBLICATIONS

19CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 16, 2025

SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells.

Ke Kong, Wei Zhao, Jonathan H Shrimp

|Mar 14, 2023

SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.

Lei Shi, William Shen, Mindy I Davis

|Apr 06, 2021

Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer.

Jason M Rohde, Surendra Karavadhi, Rajan Pragani

Pageof 1

Frequent Collaborators

3 joint publications

Matthew D Hall

2 joint publications

Samarjit Patnaik

1 joint publications

Mark J Henderson

1 joint publications

Adam Yasgar

1 joint publications

Stephen Frye

1 joint publications

Xiaodong Wang

1 joint publications

Lei Shi

1 joint publications

William Shen

1 joint publications

Mi Zhou

1 joint publications

Meng-Ju Wu

Frequent Collaborators

3 joint publications

Matthew D Hall

2 joint publications

Samarjit Patnaik

1 joint publications

Mark J Henderson

1 joint publications

Adam Yasgar

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on : Nov 01, 2019

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on : Nov 01, 2019

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

See more related videos